References
- Burnett R, François G, Kew MC, et al. hepatitis B virus and human immunodeficiency virus co-infection in sub-Saharan Africa: a call for further investigation. Liver Int 2005;25(2):201–13. http://doi.org/10.1111/j.1478-3231.2005.01054.x
- Firnhaber C, Reyneke A, Schulze D, et al. The prevalence of hepatitis B co-infection in a South African urban government HIV clinic. S Afr Med J. 2008;98:541–4.
- Mandiwana A, Tshitenge S. Prevalence of human immunodeficiency virus — hepatitis B virus co-infection amongst adult patients in Mahalapye, Ngami, Serowe, Botswana: a descriptive cross-sectional study. S Afr Fam Pract. 2017;59(3):94–7.
- Kew M. hepatitis B virus infection: the burden of disease in South Africa. South Afr J Epidemiol Infect. 2008;23(1):4–8. http://doi.org/10.1080/10158782.2008.11441293
- King J, Hagemeister D. hepatitis B co-infection in HIV-infected patients receiving antiretroviral therapy at the TC Newman Anti-Retroviral Treatment Clinic in Paarl, Western Cape. S Afr J HIV Med. 2016;17(1):541. http://doi.org/10.4102/sajhivmed.v17i1.336
- Ayuk J, Mphahlele J, Bessong P. hepatitis B virus in HIV-infected patients in Northeastern South Africa: prevalence, exposure, protection and response to HAART. S Afr Med J. 2013;103(5):330–3. http://doi.org/10.7196/SAMJ.6304
- Konopnicki, D, Mocroft A, de Wit S, et al. hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS. 2005;19(6):593–601. http://doi.org/10.1097/01.aids.0000163936.99401.fe
- Scott E, Kellerman D, Hanson A, et al. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus–infected subjects. J Infect Dis. 2003;188(4):571–7. http://doi.org/10.1086/377135
- Hoffmann C, Thio LC. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis. 2007;7(6):402–9. http://doi.org/10.1016/S1473-3099(07)70135-4
- Núñez M, Soriano V. Management of patients co-infected with hepatitis B virus and HIV. Lancet Infect Dis. 2005;5:374–82. http://doi.org/10.1016/S1473-3099(05)70141-9
- Jooste P, van Zyl A, Adland E, et al. Screening, characterisation and prevention of hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa. J Clin Virol. 2016;85:71–4. http://doi.org/10.1016/j.jcv.2016.10.017
- Abara W, Qaseem A, Schillie S, et al. hepatitis B vaccination, screening, and linkage to care: best practice advice from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med. 2017;167(11):794–804. http://doi.org/10.7326/M17-1106
- Martins S, do Livramento Ad, Andrigueti M, et al. Vaccination coverage and immunity against hepatitis B among HIV-infected patients in South Brazil. Braz J Infect Dis. 2015;19(2):181–6. http://doi.org/10.1016/j.bjid.2014.12.002
- Tedaldi EM, Baker RK, Moorman AC, et al. hepatitis A and B vaccination practices for ambulatory patients infected with HIV. Clin Infect Dis. 2004;38(10):1478–84. http://doi.org/10.1086/420740
- Phung BC, Launay O. Vaccination against viral hepatitis of HIV-1 infected patients. Hum Vaccin Immunother. 2012;8(5):554–9. http://doi.org/10.4161/hv.19105
- Tithiah N, Parboosing R, Singh L, et al. Human immunodeficiency virus and hepatitis B or C co-infection in KwaZulu- Natal: a retrospective analysis of a laboratory database.
- Coffie PA, Egger M, Vinikoor MJ, et al. Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa. BMC Infect Dis. 2017;17(Suppl 1):706. http://doi.org/10.1186/s12879-017-2768-z
- Chambal LM, Gudo ES, Carimo A, et al. HBV infection in untreated HIV-infected adults in Maputo, Mozambique. PLOS ONE. 2017;12(7):e0181836. http://doi.org/10.1371/journal.pone.0181836